10% Off
Bromolac2.5 mg
Square Pharmaceuticals PLC.
৳162.40
Add to cart
Generic medicine
Bromocriptine Mesylate: Brands, Price & Uses in Bangladesh
Bromocriptine Mesylate is a dopamine receptor agonist with the following evidence-based indications: Established / FDA-approved uses Hyperprolactinemia-associated dysfunctions: amenorrhea (with or…
About Bromocriptine Mesylate
Indications of Bromocriptine Mesylate
Bromocriptine Mesylate is a dopamine receptor agonist with the following evidence-based indications:
Established / FDA-approved uses
- Hyperprolactinemia-associated dysfunctions: amenorrhea (with or without galactorrhea), infertility, or hypogonadism caused by prolactin-secreting pituitary adenomas (micro- and macroadenomas) or idiopathic hyperprolactinemia. Bromocriptine Mesylate can also be used to reduce tumor size before surgery in patients with prolactin-secreting adenomas.
- Acromegaly: used alone or as an adjunct to pituitary irradiation or surgery to reduce elevated growth hormone levels when other therapies are inadequate or not feasible.
- Parkinson's disease: used as adjunctive therapy with levodopa (with or without a decarboxylase inhibitor) to provide additional benefit in patients experiencing tolerance or "end-of-dose" failure.
Adjunct / specific-formulation use
- A quick-release formulation of Bromocriptine Mesylate is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; this use requires a specific quick-release product and is not interchangeable with standard-release tablets/capsules.
Bromocriptine Mesylate is not indicated for suppression of physiologic lactation.
Dosage & Administration of Bromocriptine Mesylate
Dosing of Bromocriptine Mesylate is individualized by indication, started at a low dose, and titrated gradually to minimize hypotension, nausea, and dizziness. Always take with food.
| Indication | Adult Dosing |
|---|---|
| Hyperprolactinemia | Initial 1.25–2.5 mg once daily; increase by 1.25–2.5 mg every 2–7 days as tolerated. Usual therapeutic range 2.5–15 mg/day in divided doses. |
| Acromegaly | Initial 1.25–2.5 mg at bedtime for 3 days; increase by 1.25–2.5 mg every 3–7 days. Usual range 20–30 mg/day; maximum 100 mg/day. |
| Parkinson's disease (adjunct to levodopa) | Initial 1.25 mg twice daily with meals; increase by 2.5 mg/day every 14–28 days based on response and tolerability, up to a maximum of 100 mg/day. |
| Adjunct for glycemic control in type 2 diabetes (quick-release formulation only) | Initial 0.8 mg once daily within 2 hours of waking; titrate weekly by one tablet to a target of 1.6–4.8 mg/day, taken with food. |
Pediatric dosing (hyperprolactinemia, ages 11–15 years): 2.5–10 mg/day; see Use in Special Populations. Safety and efficacy of Bromocriptine Mesylate for other indications in children have not been established.
See Precautions and Warnings for blood pressure monitoring recommendations during dose initiation.
Side Effects of Bromocriptine Mesylate
Side effects of Bromocriptine Mesylate vary somewhat by indication and dose, but commonly include:
- Very common: nausea, headache, dizziness/lightheadedness, fatigue.
- Common: orthostatic (postural) hypotension, vomiting, abdominal cramps, constipation or diarrhea, nasal congestion, drowsiness.
- Less common but important: sudden onset of sleep, hallucinations and confusion (particularly in Parkinson's disease), impulse-control or compulsive behaviors (e.g., pathological gambling, hypersexuality), pleural or pericardial effusion, and retroperitoneal or cardiac valve fibrosis with prolonged high-dose use.
Starting at a low dose, titrating gradually, and taking Bromocriptine Mesylate with food reduce the frequency of gastrointestinal and hypotensive side effects. Report any severe or persistent side effect to a physician promptly.
Contraindications of Bromocriptine Mesylate
Bromocriptine Mesylate is contraindicated in patients with:
- Known hypersensitivity to Bromocriptine Mesylate, other ergot alkaloids, or any component of the formulation.
- Uncontrolled hypertension.
- Pregnancy-induced hypertension, such as pre-eclampsia or eclampsia.
These are true absolute contraindications; additional cautions (e.g., postpartum cardiovascular risk, peptic ulcer disease, psychiatric illness) are discussed under Precautions and Warnings.
Frequently Asked Questions about Bromocriptine Mesylate
What is Bromocriptine Mesylate used for?
Bromocriptine Mesylate is primarily used to treat conditions caused by high prolactin levels (such as irregular periods, infertility, and unwanted breast milk production), as adjunctive therapy for acromegaly, and as an add-on treatment for Parkinson's disease alongside levodopa. A specific quick-release formulation is also used to help control blood sugar in type 2 diabetes.
How should I take Bromocriptine Mesylate?
Take Bromocriptine Mesylate exactly as prescribed by your physician, generally with food to reduce nausea. Your doctor will start you on a low dose and gradually increase it. Do not change your dose or stop treatment without medical advice.
What are the most common side effects of Bromocriptine Mesylate?
The most common side effects are nausea, headache, dizziness, and low blood pressure on standing (especially when starting treatment). Taking Bromocriptine Mesylate with food and starting at a low dose can help reduce these effects.
Can Bromocriptine Mesylate be used during pregnancy or breastfeeding?
Bromocriptine Mesylate should be used in pregnancy only if clearly needed, as decided by your physician, since it is generally discontinued once pregnancy is confirmed for hyperprolactinemia treatment. It is not recommended during breastfeeding because it suppresses milk production; discuss your specific situation with a doctor.
Who should not take Bromocriptine Mesylate?
Bromocriptine Mesylate should not be used by people with uncontrolled high blood pressure, pregnancy-induced hypertension (such as pre-eclampsia or eclampsia), or a known allergy to Bromocriptine Mesylate or other ergot alkaloid medicines.
What should I do if I miss a dose or take too much Bromocriptine Mesylate?
If you miss a dose, take it as soon as you remember unless it is close to your next dose; do not double up. If you or someone else has taken too much Bromocriptine Mesylate and shows symptoms like severe dizziness, fainting, confusion, or hallucinations, seek immediate medical attention or contact emergency services.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.